— · biotechnology · glaucoma · ophthalmology
Who invested in Tavo Biotherapeutics
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
1
rounds observed
3
investors named
$17M
reported across those rounds
Jun 2026
most recent
The rounds
Series A · Jun 2026 · $17M
Pureos Bioventures lead, Polaris Partners, Tau Capital
Reported by Ventureburn
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.